Who invested in AngioChem?
AngioChem's investors include BDC Capital, MMV Capital Partners and VIMAC Milestone Medical Fund.
Canada · Venture startup
3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$9.8Mraised across 3 rounds since 2005, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
AngioChem's investors include BDC Capital, MMV Capital Partners and VIMAC Milestone Medical Fund.
AngioChem has raised $9.8M across 3 rounds since 2005.
AngioChem's most recent round was a Venture of $3.0M in Dec 2007.
AngioChem's largest round on record is $6.0M (Venture), in Dec 2005.
AngioChem's first round on record, in Jan 2005, was backed by BDC Capital.
AngioChem's latest named round is a Venture, in Dec 2007.
AngioChem is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.